X

pharmaceuticals

Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better…

Ocean Biomedical presents novel malaria therapeutic discoveries at NIH Laboratory of Malaria Vaccinology and Immunology

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with…

ANI Pharmaceuticals Inc (ANIP) Q4 2022 Earnings Call Transcript

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q4 2022 Earnings Call dated Mar. 09, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and…

Ocean Biomedical provides positive research data on anti-tumor pathway; stock climbs

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple…

Jazz Pharmaceuticals PLC (JAZZ) Q4 2022 Earnings Call Transcript

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox -- Executive Director, Investor Relations Bruce…

Agilent (A) Q1 2023 earnings rise on higher revenues

Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa…

Ocean Biomedical co-founder Jake Kurtis gets new patent for novel malaria vaccine target

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his…

BioMarin Pharmaceutical Inc (BMRN) Q4 2022 Earnings Call Transcript

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Traci McCarty -- Group Vice President of Investor…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the…

Zoetis Inc (ZTS) Q4 2022 Earnings Call Transcript

Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin…

Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2…

Regeneron Pharmaceuticals Inc (REGN) Q4 2022 Earnings Call Transcript

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe -- Vice President, Investor Relations…

CI Earnings: Highlights of Cigna Corp.’s Q4 2022 results

Cigna Corporation (NYSE: CI) has reported an increase in net income for the fourth quarter of 2022 when the healthcare…

Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report

Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of…

Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged…

Eli Lilly and Company (LLY) Q4 2022 Earnings Call Transcript

Eli Lilly and Company (NYSE: LLY) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President…

Eli Lilly and Company (LLY) Earnings: 4Q22 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported…

DGX Infographic: Highlights of Quest Diagnostics’ Q4 2022 earnings

Quest Diagnostics Incorporated (NYSE: DGX) has announced financial results for the fourth quarter of 2022, reporting a sharp decline in…

BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results

Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues.…

HUM Earnings: Highlights of Humana’s Q4 2022 financial results

Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7%…